Systemic sclerosis (scleroderma) trials in Switzerland

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  Where

  Sankt Gallen

  Age

  18 years and over

  People

  448 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT07497087 · EU 2025-523884-39-00
• Phase 2Taking people
  Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis

  Where

  Rheinfelden, Zurich

  Age

  18 years and over

  People

  15 worldwide

  Run by

  Topadur Pharma AG

  See details and how to joinNCT06954597 · EU 2024-511861-12-00
• Phase 3Not yet taking people in Switzerland
  A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis

  Where

  Basel, Bern, Zurich

  Age

  16 years and over

  People

  92 worldwide

  Run by

  Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

  See details and how to joinNCT07335562 · EU 2025-524337-11-00
• Phase 2Taking people
  A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis

  Where

  Sankt Gallen

  Age

  18 years and over

  People

  162 worldwide

  Run by

  Galderma R&D

  See details and how to joinNCT07047690 · EU 2025-522294-11-00